Qualigen Therapeutics is focused on revolutionizing diagnostics in healthcare settings through its innovative FastPack technology. This platform is designed to provide quick, simple, and accurate immunoassay analysis, making it suitable for use in both doctors' offices and laboratories. By streamlining the diagnostic process, FastPack technology aims to enhance patient care, reduce time and costs associated with testing, and ultimately contribute to better health outcomes.

In addition to its FastPack system, Qualigen is dedicated to developing solutions that address critical needs in the medical field. The company emphasizes the importance of creating diagnostic tools that not only improve efficiency but also have a significant impact on patient lives. Through its commitment to innovation and quality, Qualigen Therapeutics seeks to provide healthcare professionals with reliable resources that facilitate timely and effective decision-making in patient care.

United States

Qualigen Therapeutics, Inc. is a clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company is dedicated to developing novel therapeutics for the treatment of cancer and infectious diseases.

Qualigen Therapeutics

Company Details